# Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants

> **NCT01662999** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 42 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT01662999
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2015-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01662999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01662999, "Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01662999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*